本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectar Biosciences Inc.

4.88
-0.0500-1.01%
盘后4.78-0.1000-2.05%19:58 EDT
成交量:6.17万
成交额:30.40万
市值:1,394.22万
市盈率:-0.21
高:5.05
开:4.96
低:4.80
收:4.93
数据加载中...
2019/08/26

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/20

交易所摘牌声明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2019/08/15

重要事件披露

Current report, items 5.02 and 9.01
2019/08/14

重要事件披露

Current report, items 7.01 and 9.01
2019/08/12

重要事件披露

Current report, items 2.02 and 9.01
2019/08/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/09

重要事件披露

Current report, items 7.01 and 9.01
2019/06/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

重要事件披露

Current report, items 5.02, 5.07, and 9.01
2019/06/11

SEC问询函

[Cover]Correspondence
2019/05/31

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/05/21

重要事件披露

Current report, items 7.01 and 9.01
2019/05/20

重要事件披露

Current report, items 1.01, 3.02, 7.01, and 9.01
2019/05/16

重要事件披露

Current report, items 7.01 and 9.01
2019/05/15

重要事件披露

Current report, items 7.01 and 9.01